Predict your next investment

Corporation
rsm.global

See what CB Insights has to offer

Investments

1

Partners & Customers

10

About RSM International

RSM International is a provider of audit, tax, and consulting services.

RSM International Headquarter Location

50 Cannon Street

London, England, EC4N 6JJ,

United Kingdom

+44 207 601 1080

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Latest RSM International News

Biocept Appoints RSM as Independent Auditor

Jun 27, 2022

June 27, 2022 08:00 AM Eastern Daylight Time SAN DIEGO--( BUSINESS WIRE )-- Biocept, Inc . (Nasdaq: BIOC), a leading provider of molecular diagnostic assays, products and services, announces the appointment of RSM US LLP (“RSM”) as its independent registered public accounting firm effective June 24, 2022. RSM was recently ranked the fifth largest accounting, tax and consulting services firm in the U.S. for the 16th straight year by Accounting Today. (“MHM”), which notified the company on April 7, 2022 of its decision to decline to stand for re-appointment as the company’s independent registered public accounting firm. The decision by MHM was not the result of any disagreement with the company. MHM’s audit reports on the company’s financial statements as of and for the years ended December 31, 2021 and 2020 did not contain an adverse opinion or a disclaimer of opinion and were not qualified or modified as to uncertainty, audit scope or accounting principles. About RSM US LLP RSM’s purpose is to deliver the power of being understood to our clients, colleagues and communities through world-class audit, tax and consulting services focused on middle market businesses. The clients we serve are the engine of global commerce and economic growth, and we are focused on developing leading professionals and services to meet their evolving needs in today’s ever-changing business environment. RSM US LLP is the U.S. member of RSM International, a global network of independent audit, tax and consulting firms with 51,000 people across 123 countries. For more information, visit rsmus.com , like us on Facebook , follow us on Twitter and/or connect with us on LinkedIn . About Biocept, Inc. Biocept, Inc. develops and commercializes molecular diagnostic assays that provide physicians with clinically actionable information for treating and monitoring patients diagnosed with a variety of cancers. Biocept has developed and is commercializing the CNSide™ cerebrospinal fluid assay that detects cancer cells that have metastasized to the central nervous system. Biocept’s patented Target Selector™ technology captures and quantitatively analyzes CSF tumor cells for tumor-associated molecular markers, using technology first developed for use in blood. Biocept also is leveraging its molecular diagnostic capabilities to offer nationwide COVID-19 RT-PCR testing to support public health efforts. For more information, visit www.biocept.com . Forward-Looking Statements Disclaimer This news release contains forward-looking statements that are based upon current expectations or beliefs, as well as a number of assumptions about future events. Although we believe that the expectations reflected in the forward-looking statements and the assumptions upon which they are based are reasonable, we can give no assurance that such expectations and assumptions will prove to be correct. Forward-looking statements are generally identifiable by the use of words like "may," "will," "should," "could," "expect," "anticipate," "estimate," "believe," "intend" or "project," or the negative of these words or other variations on these words or comparable terminology. To the extent that statements in this news release are not strictly historical, including, without limitation, statements as to the ability of CNSide to impact life expectancy and quality of life, our ability to establish CNSide as the new standard of care for the diagnosis of patients with suspected cancer metastasis to the CNS, our ability to expand our CSF testing menu for additional tumor types and biomarkers in the future, and our ability to provide physicians with clinically actionable information for treating and monitoring patients diagnosed with a variety of cancers, such statements are forward-looking, and are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. The reader is cautioned not to put undue reliance on these forward-looking statements, as these statements are subject to numerous risk factors as set forth in our Securities and Exchange Commission (SEC) filings. The effects of such risks and uncertainties could cause actual results to differ materially from the forward-looking statements contained in this news release. We do not plan to update any such forward-looking statements and expressly disclaim any duty to update the information contained in this press release except as required by law. Readers are advised to review our filings with the SEC at http://www.sec.gov/ . Contacts

RSM International Investments

1 Investments

RSM International has made 1 investments. Their latest investment was in Creative Support as part of their Debt on July 7, 2020.

CBI Logo

RSM International Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

7/31/2020

Debt

Creative Support

$32.74M

Yes

1

Date

7/31/2020

Round

Debt

Company

Creative Support

Amount

$32.74M

New?

Yes

Co-Investors

Sources

1

RSM International Acquisitions

12 Acquisitions

RSM International acquired 12 companies. Their latest acquisition was Pemom on May 25, 2022.

Date

Investment Stage

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Total Funding

Note

Sources

5/25/2022

$99M

Merger

2

8/6/2021

$99M

Acquired

1

12/20/2019

$99M

Acquired

1

12/4/2019

Subscribe to see more

$99M

Subscribe to see more

10

9/6/2019

Subscribe to see more

$99M

Subscribe to see more

10

Date

5/25/2022

8/6/2021

12/20/2019

12/4/2019

9/6/2019

Investment Stage

Companies

Subscribe to see more

Subscribe to see more

Valuation

$99M

$99M

$99M

$99M

$99M

Total Funding

Note

Merger

Acquired

Acquired

Subscribe to see more

Subscribe to see more

Sources

2

1

1

10

10

RSM International Partners & Customers

10 Partners and customers

RSM International has 10 strategic partners and customers. RSM International recently partnered with Re-Leased on March 3, 2022.

Date

Type

Business Partner

Country

News Snippet

Sources

3/23/2022

Partner

New Zealand

1

3/2/2022

Partner

RSM Australia and CMH Practice Management partnership

RSM Australia and CMH Practice Management 's partnership to boost innovation and financial security in healthcare .

1

3/18/2021

Vendor

United States

RSM Selects Lukka to Support Crypto Asset Valuations

Lukka , which has recently announced notable partnerships with S&P Dow Jones Indices and IHS Markit involving its data products , will now supply RSM International 's valuation practice with Lukka , the world 's first Fair Market Value pricing data for crypto assets .

1

3/4/2021

Partner

United States

Subscribe to see more

Subscribe to see more

10

10/29/2020

Partner

Subscribe to see more

Subscribe to see more

10

Date

3/23/2022

3/2/2022

3/18/2021

3/4/2021

10/29/2020

Type

Partner

Partner

Vendor

Partner

Partner

Business Partner

Country

New Zealand

United States

United States

News Snippet

RSM Australia and CMH Practice Management partnership

RSM Australia and CMH Practice Management 's partnership to boost innovation and financial security in healthcare .

RSM Selects Lukka to Support Crypto Asset Valuations

Lukka , which has recently announced notable partnerships with S&P Dow Jones Indices and IHS Markit involving its data products , will now supply RSM International 's valuation practice with Lukka , the world 's first Fair Market Value pricing data for crypto assets .

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Sources

1

1

1

10

10

RSM International Team

1 Team Member

RSM International has 1 team member, including former Executive Vice President, James Blayney.

Name

Work History

Title

Status

James Blayney

Executive Vice President

Former

Name

James Blayney

Work History

Title

Executive Vice President

Status

Former

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.